Grigory Volchenkov

1.8k total citations
17 papers, 408 citations indexed

About

Grigory Volchenkov is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Grigory Volchenkov has authored 17 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Grigory Volchenkov's work include Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (6 papers) and Infectious Diseases and Tuberculosis (4 papers). Grigory Volchenkov is often cited by papers focused on Tuberculosis Research and Epidemiology (13 papers), Mycobacterium research and diagnosis (6 papers) and Infectious Diseases and Tuberculosis (4 papers). Grigory Volchenkov collaborates with scholars based in United States, Russia and Uganda. Grigory Volchenkov's co-authors include Janet L. Larson, Wendy M. Woith, Ekaterina V. Kurbatova, Julia Ershova, Boris Y. Kazennyy, Petros Isaakidis, Kai Kliiman, Hee Jin Kim, Charlotte Kvasnovsky and Vaira Leimane and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

In The Last Decade

Grigory Volchenkov

14 papers receiving 394 citations

Peers

Grigory Volchenkov
H Lucy Thomas United Kingdom
Karen Shean South Africa
Avika Dixit United States
Rosa Yataco United States
Ivan Solovič Slovakia
H Lucy Thomas United Kingdom
Grigory Volchenkov
Citations per year, relative to Grigory Volchenkov Grigory Volchenkov (= 1×) peers H Lucy Thomas

Countries citing papers authored by Grigory Volchenkov

Since Specialization
Citations

This map shows the geographic impact of Grigory Volchenkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grigory Volchenkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grigory Volchenkov more than expected).

Fields of papers citing papers by Grigory Volchenkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grigory Volchenkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grigory Volchenkov. The network helps show where Grigory Volchenkov may publish in the future.

Co-authorship network of co-authors of Grigory Volchenkov

This figure shows the co-authorship network connecting the top 25 collaborators of Grigory Volchenkov. A scholar is included among the top collaborators of Grigory Volchenkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grigory Volchenkov. Grigory Volchenkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Volchenkov, Grigory, et al.. (2025). Operational Study of Efficacy and Safety of 9-Month Multi- and Pre-Extesively Drug Resistant Tuberculosis Therapy in the Russian Federation. Annals of the Russian academy of medical sciences. 80(2). 97–108.
2.
Volchenkov, Grigory, et al.. (2022). Safety and Efficacy of Multiple Drug Resistant Tuberculosis Treatment in Patients with Different HIV Statuses. SHILAP Revista de lepidopterología. 100(1). 33–40.
3.
Cegielski, J. Peter, Carrie Tudor, Grigory Volchenkov, & Paul Jensen. (2021). Antimicrobial drug resistance and infection prevention/control: lessons from tuberculosis. International journal of infection control. 8 indexed citations
4.
Volchenkov, Grigory. (2021). Experience with UV‐C Air Disinfection in Some Russian Hospitals. Photochemistry and Photobiology. 97(3). 549–551. 8 indexed citations
5.
Ershova, Julia, Grigory Volchenkov, Olga V. Demikhova, et al.. (2020). Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia. BMC Infectious Diseases. 20(1). 543–543. 8 indexed citations
6.
Volchenkov, Grigory, et al.. (2020). A clinical-epidemiological characteristic of mycobacteriosis in two subjects of the Russian Federation. Infekcionnye bolezni. 35–42.
7.
Silva, Diego S., et al.. (2020). Ethics and human rights considerations regarding involuntary isolation of people with TB. The International Journal of Tuberculosis and Lung Disease. 24(5). 15–20. 1 indexed citations
8.
Se, Borisov, E. M. Bogorodskaya, Grigory Volchenkov, et al.. (2018). EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS. Tuberculosis and lung diseases. 96(3). 6–18. 27 indexed citations
9.
Volchenkov, Grigory, et al.. (2017). BIOSAFETY PROVISIONS IN BACTERIOLOGICAL LABORATORIES OF THE RUSSIAN TB UNITS. Tuberculosis and lung diseases. 95(5). 18–23. 1 indexed citations
10.
Cutsem, Gilles Van, et al.. (2016). Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key: Table 1.. Clinical Infectious Diseases. 62(suppl 3). S238–S243. 54 indexed citations
11.
Ershova, Julia, et al.. (2015). Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia. Emerging infectious diseases. 21(11). 2048–2051. 9 indexed citations
12.
Kurbatova, Ekaterina V., Tracy Dalton, Julia Ershova, et al.. (2015). Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries. Emerging infectious diseases. 21(6). 977–983. 11 indexed citations
13.
Dalton, Tracy, Peter Cegielski, Somsak Akksilp, et al.. (2012). Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. The Lancet. 380(9851). 1406–1417. 163 indexed citations
14.
Kurbatova, Ekaterina V., Denise A. Kaminski, В В Ерохин, et al.. (2012). Performance of Cepheid® Xpert MTB/RIF® and TB-Biochip® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases. 32(6). 735–743. 22 indexed citations
15.
Woith, Wendy M., Grigory Volchenkov, & Janet L. Larson. (2012). Barriers and motivators affecting tuberculosis infection control practices of Russian health care workers. The International Journal of Tuberculosis and Lung Disease. 16(8). 1092–1096. 43 indexed citations
16.
Woith, Wendy M., Grigory Volchenkov, & Janet L. Larson. (2010). Russian health care workers' knowledge of tuberculosis and infection control.. PubMed. 14(11). 1489–92. 35 indexed citations
17.
Jakubowiak, Wieslaw, et al.. (2009). Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.. PubMed. 13(10). 1309–12. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026